Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether Socheongryong-tang (SCRT) and Yeongyopaedok-san (YPS) are effective in the treatment of upper respiratory tract infection.
Upper respiratory tract infections (URTIs) are the most prevalent disease of human beings, it incur a significant health burden on populations in terms of human suffering and economic losses. Usually, antibiotic therapy is not helpful since most infections are virally induced. Over 200 serologically different viral types are responsible for human URTIs, so that preventions of URTIs including vaccination are impassable. SCRT and YPS are widely used to treat the respiratory disease. The objective of this study is to determine the efficacy of SCRT and YPS in symptomatic relief of patients with URTIs.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Experimental | Placebo (encapsulated starch + lactose) |
|
| SCRT(Socheongryong-tang ) | Experimental | encapsulated Socheongryong-tang extract |
|
| YPS (Yeongyopaedok-san) | Experimental | Encapsulated Yeongyopaedok-san extract |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SCRT | Drug | 4 capsules,three times daily, for 7days or within symptom disappearance |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes of score daily measured by WURSS-K before, during and after treatment | daily (7 days) |
| Measure | Description | Time Frame |
|---|---|---|
| Time of symptom disappearance | daily | |
| Changes of score daily measured by WURSS-K before, during and after treatment in pattern identification | daily (7days) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| YangChun Park, Ph. D. | Daejeon University | Principal Investigator |
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Mar 10, 2014 | |
| Reset | Apr 15, 2014 | |
| Release | Feb 22, 2016 | |
| Reset | Mar 22, 2016 | |
| Release | Aug 13, 2019 | |
| Reset | Aug 23, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Mar 10, 2014 | Apr 15, 2014 | |||
| Feb 22, 2016 |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| ID | Term |
|---|---|
| D007239 | Infections |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C090832 | sho-seiryu-to |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| YPS | Drug | 4 capsules, three times daily, for 7days or within symptom disappearance |
|
|
| Placebo | Drug | 4 capsules, three times daily, for 7days or within symptom disappearance |
|
| Mar 22, 2016 |
| Aug 13, 2019 | Aug 23, 2019 |